S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study

The safety and efficacy of S-1 plus cisplatin in Chinese advanced gastric cancer patients in first line setting is unknown. In this pilot study, patients with advanced gastric or gastro-esophageal junction adenocarcinoma were enrolled and randomly assigned in a 1:1 ratio to receive S-1 plus cisplati...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuhong, Qiu, Miaozhen, Xu, Jianming, Sun, Guoping, Lu, Huishan, Liu, Yunpeng, Zhong, Meizuo, Zhang, Helong, Yu, Shiying, Li, Wei, Hu, Xiaohua, Wang, Jiejun, Cheng, Ying, Zhou, Juntian, Guo, Zengqing, Guan, Zhongzhen, Xu, Ruihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741513/
https://www.ncbi.nlm.nih.gov/pubmed/26439700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741513/
https://www.ncbi.nlm.nih.gov/pubmed/26439700

Ejemplares similares